http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2420565-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d2e92e75d6d11617c9be9192d5504fae http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_32e26f75168cc64d9228ed6f618137f7 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N63-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23K1-165 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-00 |
| filingDate | 2010-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fa55a1b5bd95861e5fc77778ae6ffb3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b1e14dcaba17b4d0babe220217cebaf |
| publicationDate | 2011-06-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2420565-C1 |
| titleOfInvention | Method of producing biological product for mycotoxin elimination from raw feed and biological product produced by such method |
| abstract | FIELD: medicine. n SUBSTANCE: method of producing a biological product provides mixing of mixed sorbents, Riboxinum, lecithin, L-carnitine, organic acid selected from succinic acid or propionic acid or their salt, mixed oligofructose and inulin and an enzymatic proteolytic agent of a cultural fluid of bacteria Bacillus subtilis 'Protosubtilinum'. The contents of the mixed ingredients is, g per one kg of the produced agent: Riboxinum - 15-20, lecithin 20-30, L-carnitine - 15-20, organic acid - succinic or propionic acid or their salts - 10-15, mixed oligofructose and inulin 30:70 - 30-50, the enzymatic proteolytic agent 'Protosubtilinum' - 25-30, a sorbent selected from aluminium silicates - zeolites or bentonites, and a sorbent selected from a group of laminated sorbents - vermiculite or montmorillonite, in the ratio 5:1 respectively - the rest. n EFFECT: biological product exhibits high fungistatic activity, sorbing ability and enhanced bioprotective function. n 2 cl, 7 tbl, 4 ex |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/MD-849-Z http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2568756-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2743197-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2502319-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2493725-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2649884-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2552872-C1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2588645-C2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2782383-C1 |
| priorityDate | 2010-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 44.